Peter Lamb Insider Trading $EXEL EXELIXIS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Peter Lamb.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter Lamb. Peter Lamb is EVP, Discovery Research & CSO in EXELIXIS, INC. ($EXEL) and EVP, Scientific Strategy & CSO in EXELIXIS, INC. ($EXEL) and SVP, Discovery Research & CSO in EXELIXIS, INC. ($EXEL).
Peter Lamb in EXELIXIS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Peter Lamb: EVP, Scientific Strategy & CSO, EVP, Discovery Research & CSO, SVP, Discovery Research & CSO
Holdings: 449,467 shares
Current Value: $9,245,536
Latest Transaction: Apr 02 2021
$EXEL Market Capitalization: $6.19B
$EXEL Previous Close: $20.57
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter Lamb in EXELIXIS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 1.70 | 60,000 | 102,000 | 0 | |
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 22.96 | 60,000 | 1,377,600 | 389,467 | 449.5 K to 389.5 K (-13.35 %) |
| Apr 02 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 1.70 | 60,000 | 102,000 | 449,467 | 389.5 K to 449.5 K (+15.41 %) |
| Mar 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 49,395 | 0 | 389,467 | 340.1 K to 389.5 K (+14.52 %) |
| Mar 03 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 1.70 | 65,000 | 110,500 | 60,000 | |
| Mar 03 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 22.11 | 65,000 | 1,437,150 | 340,072 | 405.1 K to 340.1 K (-16.05 %) |
| Mar 03 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 1.70 | 65,000 | 110,500 | 405,072 | 340.1 K to 405.1 K (+19.11 %) |
| Feb 17 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 21.91 | 3,718 | 81,461 | 340,072 | 343.8 K to 340.1 K (-1.08 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 22.56 | 19,997 | 451,132 | 343,790 | 363.8 K to 343.8 K (-5.50 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 71,293 | 0 | 363,787 | 292.5 K to 363.8 K (+24.37 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 9,370 | 0 | 292,494 | 283.1 K to 292.5 K (+3.31 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 22.56 | 19,997 | 451,132 | 343,790 | 363.8 K to 343.8 K (-5.50 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 71,293 | 0 | 363,787 | 292.5 K to 363.8 K (+24.37 %) |
| Feb 05 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 9,370 | 0 | 292,494 | 283.1 K to 292.5 K (+3.31 %) |
| Feb 03 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 1.70 | 65,000 | 110,500 | 125,000 | |
| Feb 03 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 22.08 | 65,000 | 1,435,200 | 283,124 | 348.1 K to 283.1 K (-18.67 %) |
| Feb 03 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 1.70 | 65,000 | 110,500 | 348,124 | 283.1 K to 348.1 K (+22.96 %) |
| Jan 06 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 1.70 | 65,000 | 110,500 | 190,000 | |
| Jan 06 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 20.32 | 65,000 | 1,320,800 | 283,124 | 348.1 K to 283.1 K (-18.67 %) |
| Jan 06 2021 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 1.70 | 65,000 | 110,500 | 348,124 | 283.1 K to 348.1 K (+22.96 %) |
| Dec 22 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 1.70 | 65,000 | 110,500 | 255,000 | |
| Dec 22 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 20.01 | 65,000 | 1,300,650 | 283,124 | 348.1 K to 283.1 K (-18.67 %) |
| Dec 22 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 1.70 | 65,000 | 110,500 | 348,124 | 283.1 K to 348.1 K (+22.96 %) |
| Nov 17 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 20.16 | 2,014 | 40,602 | 283,124 | 285.1 K to 283.1 K (-0.71 %) |
| Nov 17 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 20.16 | 6,818 | 137,451 | 285,138 | 292 K to 285.1 K (-2.34 %) |
| Nov 17 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 20.16 | 2,479 | 49,977 | 291,956 | 294.4 K to 292 K (-0.84 %) |
| Oct 26 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 21.79 | 53,022 | 1,155,349 | 294,435 | 347.5 K to 294.4 K (-15.26 %) |
| Oct 26 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 213,879 | 0 | 347,457 | 133.6 K to 347.5 K (+160.12 %) |
| Sep 04 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 21.58 | 2,323 | 50,130 | 133,578 | 135.9 K to 133.6 K (-1.71 %) |
| Sep 04 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 9,370 | 0 | 135,901 | 126.5 K to 135.9 K (+7.41 %) |
| Jun 10 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 5.51 | 26,000 | 143,260 | 0 | |
| Jun 10 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 22.56 | 26,000 | 586,560 | 126,531 | 152.5 K to 126.5 K (-17.05 %) |
| Jun 10 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 5.51 | 26,000 | 143,260 | 152,531 | 126.5 K to 152.5 K (+20.55 %) |
| May 08 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 5.51 | 50,000 | 275,500 | 26,000 | |
| May 08 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 25.54 | 50,000 | 1,277,000 | 126,531 | 176.5 K to 126.5 K (-28.32 %) |
| May 08 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 5.51 | 50,000 | 275,500 | 176,531 | 126.5 K to 176.5 K (+39.52 %) |
| Apr 08 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 5.51 | 50,000 | 275,500 | 76,000 | |
| Apr 08 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 17.26 | 50,000 | 863,000 | 126,531 | 176.5 K to 126.5 K (-28.32 %) |
| Apr 08 2020 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 5.51 | 50,000 | 275,500 | 176,531 | 126.5 K to 176.5 K (+39.52 %) |
| Dec 06 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 17.67 | 3,872 | 68,418 | 126,531 | 130.4 K to 126.5 K (-2.97 %) |
| Dec 06 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 14,993 | 0 | 130,403 | 115.4 K to 130.4 K (+12.99 %) |
| Nov 15 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 16.51 | 2,099 | 34,654 | 115,410 | 117.5 K to 115.4 K (-1.79 %) |
| Nov 15 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 16.51 | 2,099 | 34,654 | 115,410 | 117.5 K to 115.4 K (-1.79 %) |
| Nov 15 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 16.51 | 7,102 | 117,254 | 117,509 | 124.6 K to 117.5 K (-5.70 %) |
| Nov 15 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 16.51 | 7,102 | 117,254 | 117,509 | 124.6 K to 117.5 K (-5.70 %) |
| Sep 13 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 19.26 | 2,581 | 49,710 | 124,611 | 127.2 K to 124.6 K (-2.03 %) |
| Sep 13 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 9,995 | 0 | 127,192 | 117.2 K to 127.2 K (+8.53 %) |
| Sep 13 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 19.26 | 2,581 | 49,710 | 124,611 | 127.2 K to 124.6 K (-2.03 %) |
| Sep 13 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 9,995 | 0 | 127,192 | 117.2 K to 127.2 K (+8.53 %) |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 5.51 | 17,404 | 95,896 | 0 | |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 5.51 | 24,596 | 135,524 | 17,404 | |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 1.70 | 75,404 | 128,187 | 320,000 | |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 1.70 | 4,596 | 7,813 | 395,404 | |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 5.56 | 95,404 | 530,446 | 0 | |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 20.76 | 17,404 | 361,307 | 117,197 | 134.6 K to 117.2 K (-12.93 %) |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 5.51 | 17,404 | 95,896 | 134,601 | 117.2 K to 134.6 K (+14.85 %) |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 20.67 | 100,000 | 2,067,000 | 117,197 | 217.2 K to 117.2 K (-46.04 %) |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 5.51 | 24,596 | 135,524 | 217,197 | 192.6 K to 217.2 K (+12.77 %) |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 1.70 | 75,404 | 128,187 | 192,601 | 117.2 K to 192.6 K (+64.34 %) |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 20.49 | 100,000 | 2,049,000 | 117,197 | 217.2 K to 117.2 K (-46.04 %) |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 1.70 | 4,596 | 7,813 | 217,197 | 212.6 K to 217.2 K (+2.16 %) |
| Jun 19 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 5.56 | 95,404 | 530,446 | 212,601 | 117.2 K to 212.6 K (+81.40 %) |
| Jun 14 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 5.56 | 27,596 | 153,434 | 95,404 | |
| Jun 14 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 20.03 | 27,596 | 552,748 | 117,197 | 144.8 K to 117.2 K (-19.06 %) |
| Jun 14 2019 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 5.56 | 27,596 | 153,434 | 144,793 | 117.2 K to 144.8 K (+23.55 %) |
| Nov 16 2018 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 17.45 | 2,098 | 36,610 | 117,197 | 119.3 K to 117.2 K (-1.76 %) |
| Nov 16 2018 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 17.45 | 7,101 | 123,912 | 119,295 | 126.4 K to 119.3 K (-5.62 %) |
| Sep 12 2018 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | A | 18.80 | 124,341 | 2,337,611 | 124,341 | |
| Nov 17 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 24.75 | 2,204 | 54,549 | 126,396 | 128.6 K to 126.4 K (-1.71 %) |
| Oct 05 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | A | 24.41 | 110,000 | 2,685,100 | 110,000 | |
| Oct 05 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 55,000 | 0 | 128,600 | 73.6 K to 128.6 K (+74.73 %) |
| Mar 03 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 7.51 | 25,000 | 187,750 | 0 | |
| Mar 03 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 7.18 | 20,000 | 143,600 | 0 | |
| Mar 03 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 22.19 | 45,000 | 998,550 | 73,600 | 118.6 K to 73.6 K (-37.94 %) |
| Mar 03 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 7.51 | 25,000 | 187,750 | 118,600 | 93.6 K to 118.6 K (+26.71 %) |
| Mar 03 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 7.18 | 20,000 | 143,600 | 93,600 | 73.6 K to 93.6 K (+27.17 %) |
| Feb 03 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 7.18 | 55,000 | 394,900 | 20,000 | |
| Feb 03 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 5.96 | 15,000 | 89,400 | 0 | |
| Feb 03 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 18.65 | 70,000 | 1,305,500 | 73,600 | 143.6 K to 73.6 K (-48.75 %) |
| Feb 03 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 7.18 | 55,000 | 394,900 | 143,600 | 88.6 K to 143.6 K (+62.08 %) |
| Feb 03 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 5.96 | 15,000 | 89,400 | 88,600 | 73.6 K to 88.6 K (+20.38 %) |
| Jan 05 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 5.96 | 60,000 | 357,600 | 15,000 | |
| Jan 05 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 4.42 | 10,000 | 44,200 | 0 | |
| Jan 05 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 15.27 | 2,400 | 36,648 | 73,600 | 76 K to 73.6 K (-3.16 %) |
| Jan 05 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 14.63 | 67,600 | 988,988 | 76,000 | 143.6 K to 76 K (-47.08 %) |
| Jan 05 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 5.96 | 60,000 | 357,600 | 143,600 | 83.6 K to 143.6 K (+71.77 %) |
| Jan 05 2017 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 4.42 | 10,000 | 44,200 | 83,600 | 73.6 K to 83.6 K (+13.59 %) |
| Dec 02 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 4.42 | 15,000 | 66,300 | 10,000 | |
| Dec 02 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 5.50 | 55,000 | 302,500 | 0 | |
| Dec 02 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 16.66 | 70,000 | 1,166,200 | 73,600 | 143.6 K to 73.6 K (-48.75 %) |
| Dec 02 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 4.42 | 15,000 | 66,300 | 143,600 | 128.6 K to 143.6 K (+11.66 %) |
| Dec 02 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 5.50 | 55,000 | 302,500 | 128,600 | 73.6 K to 128.6 K (+74.73 %) |
| Nov 14 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 5.50 | 20,000 | 110,000 | 55,000 | |
| Nov 14 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | M | 5.04 | 50,000 | 252,000 | 0 | |
| Nov 14 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Sell | S | 13.15 | 70,000 | 920,500 | 73,600 | 143.6 K to 73.6 K (-48.75 %) |
| Nov 14 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 5.50 | 20,000 | 110,000 | 143,600 | 123.6 K to 143.6 K (+16.18 %) |
| Nov 14 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Buy | M | 5.04 | 50,000 | 252,000 | 123,600 | 73.6 K to 123.6 K (+67.93 %) |
| Sep 26 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | A | 14.74 | 97,500 | 1,437,150 | 97,500 | |
| Sep 26 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 16,250 | 0 | 73,600 | 57.4 K to 73.6 K (+28.33 %) |
| Apr 29 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | A | 1.90 | 43,750 | 83,125 | 43,750 | |
| Apr 29 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | A | 1.70 | 100,000 | 170,000 | 100,000 | |
| Mar 08 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | A | 1.90 | 43,750 | 83,125 | 43,750 | |
| Mar 08 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | A | 1.70 | 100,000 | 170,000 | 100,000 | |
| Feb 16 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Option Exercise | A | 4.20 | 40,000 | 168,000 | 40,000 | |
| Feb 16 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Payment of Exercise | F | 4.20 | 25,454 | 106,907 | 57,350 | 82.8 K to 57.4 K (-30.74 %) |
| Feb 16 2016 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Scientific Str ... | Grant | A | 0.00 | 45,378 | 0 | 82,804 | 37.4 K to 82.8 K (+121.25 %) |
| Nov 17 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 0.00 | 2,083 | 0 | 0 | |
| Nov 17 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Payment of Exercise | F | 0.00 | 1,130 | 0 | 37,426 | 38.6 K to 37.4 K (-2.93 %) |
| Nov 17 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 0.00 | 2,083 | 0 | 38,556 | 36.5 K to 38.6 K (+5.71 %) |
| Oct 19 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 24,001 | 135,126 | 0 | |
| Oct 19 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 12,667 | 71,315 | 24,001 | |
| Oct 19 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 12,000 | 67,560 | 36,668 | |
| Oct 19 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 2,881 | 16,220 | 48,668 | |
| Oct 19 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Sell | S | 5.80 | 51,549 | 298,984 | 36,473 | 88 K to 36.5 K (-58.56 %) |
| Oct 19 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 24,001 | 135,126 | 88,022 | 64 K to 88 K (+37.49 %) |
| Oct 19 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 12,667 | 71,315 | 64,021 | 51.4 K to 64 K (+24.67 %) |
| Oct 19 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 12,000 | 67,560 | 51,354 | 39.4 K to 51.4 K (+30.49 %) |
| Oct 19 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 2,881 | 16,220 | 39,354 | 36.5 K to 39.4 K (+7.90 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 600 | 3,378 | 51,549 | |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 56,936 | 320,550 | 52,149 | |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 39,583 | 222,852 | 0 | |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 39,999 | 225,194 | 39,583 | |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 19,333 | 108,845 | 79,582 | |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 84,000 | 472,920 | 98,915 | |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 28,000 | 157,640 | 182,915 | |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 20,000 | 112,600 | 210,915 | |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 8,000 | 45,040 | 230,915 | |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 2,500 | 14,075 | 238,915 | |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 1,400 | 7,882 | 241,415 | |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | M | 5.63 | 525 | 2,956 | 242,815 | |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Sell | S | 5.80 | 600 | 3,480 | 36,473 | 37.1 K to 36.5 K (-1.62 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 600 | 3,378 | 37,073 | 36.5 K to 37.1 K (+1.65 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Sell | S | 5.84 | 300,276 | 1,753,312 | 36,473 | 336.7 K to 36.5 K (-89.17 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 56,936 | 320,550 | 336,749 | 279.8 K to 336.7 K (+20.35 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 39,583 | 222,852 | 279,813 | 240.2 K to 279.8 K (+16.48 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 39,999 | 225,194 | 240,230 | 200.2 K to 240.2 K (+19.98 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 19,333 | 108,845 | 200,231 | 180.9 K to 200.2 K (+10.69 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 84,000 | 472,920 | 180,898 | 96.9 K to 180.9 K (+86.69 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 28,000 | 157,640 | 96,898 | 68.9 K to 96.9 K (+40.64 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 20,000 | 112,600 | 68,898 | 48.9 K to 68.9 K (+40.90 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 8,000 | 45,040 | 48,898 | 40.9 K to 48.9 K (+19.56 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 2,500 | 14,075 | 40,898 | 38.4 K to 40.9 K (+6.51 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 1,400 | 7,882 | 38,398 | 37 K to 38.4 K (+3.78 %) |
| Oct 14 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Buy | M | 5.63 | 525 | 2,956 | 36,998 | 36.5 K to 37 K (+1.44 %) |
| Sep 18 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | A | 6.21 | 190,000 | 1,179,900 | 190,000 | |
| Jul 22 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | A | 1.90 | 87,500 | 166,250 | 87,500 | |
| Jul 22 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | A | 1.70 | 200,000 | 340,000 | 200,000 | |
| Jul 22 2015 | EXEL | EXELIXIS, INC. | Lamb Peter | EVP, Discovery Rese ... | Option Exercise | A | 5.51 | 42,000 | 231,420 | 42,000 | |
| Dec 10 2007 | EXEL | EXELIXIS, INC. | Lamb Peter | SVP, Discovery Rese ... | Option Exercise | A | 9.91 | 125,000 | 1,238,750 | 125,000 | |
| Jan 23 2007 | EXEL | EXELIXIS, INC. | Lamb Peter | SVP, Discovery Rese ... | Option Exercise | A | 9.85 | 40,000 | 394,000 | 40,000 |
Page: 1